204 related articles for article (PubMed ID: 10465136)
1. Clinical remission of xeroderma pigmentosum-associated squamous cell carcinoma with isotretinoin and chemotherapy: case report.
Saade M; Debahy NE; Houjeily S
J Chemother; 1999 Aug; 11(4):313-7. PubMed ID: 10465136
[TBL] [Abstract][Full Text] [Related]
2. Role of isotretinoin in cancer prevention and management in malignancies associated with xeroderma pigmentosum.
Zaman S; Gillani JA; Nabeela ; Khattak R; Iqbal ; ul Ain N; Zanaib ; Fayyaz
J Ayub Med Coll Abbottabad; 2014; 26(2):255-7. PubMed ID: 25603690
[TBL] [Abstract][Full Text] [Related]
3. Treatment of cancer in a child with ocular xeroderma pigmentosa (XP) in Malawi.
Schulze Schwering M; Chagaluka G; Molyneux E
J Pediatr Hematol Oncol; 2014 Nov; 36(8):e540-2. PubMed ID: 24390455
[TBL] [Abstract][Full Text] [Related]
4. Cancer protection in xeroderma pigmentosum variant (XP-V).
Somos S; Farkas B; Schneider I
Anticancer Res; 1999; 19(3B):2195-9. PubMed ID: 10472330
[TBL] [Abstract][Full Text] [Related]
5. Rapid response of metastatic cutaneous squamous cell carcinoma to pembrolizumab in a patient with xeroderma pigmentosum: Case report and review of the literature.
Deinlein T; Lax SF; Schwarz T; Giuffrida R; Schmid-Zalaudek K; Zalaudek I
Eur J Cancer; 2017 Sep; 83():99-102. PubMed ID: 28734147
[No Abstract] [Full Text] [Related]
6. Xeroderma pigmentosum: spinal cord astrocytoma with 9-year survival after radiation and isotretinoin therapy.
DiGiovanna JJ; Patronas N; Katz D; Abangan D; Kraemer KH
J Cutan Med Surg; 1998 Jan; 2(3):153-8. PubMed ID: 9479081
[TBL] [Abstract][Full Text] [Related]
7. [Topical and systemic chemotherapy with 5-fluouracil in facial carcinoma secondary to xeroderma pigmentosum].
Khader A; Gritli S; Boussen I; Oueslati Z; Ferjaoui M; Nouira R; Ladgham A; Boussen H
Tunis Med; 2005 Nov; 83(11):672-4. PubMed ID: 16422364
[TBL] [Abstract][Full Text] [Related]
8. Effect of isotretinoin therapy on natural killer cell activity in patients with xeroderma pigmentosum.
Anolik JH; Di Giovanna JJ; Gaspari AA
Br J Dermatol; 1998 Feb; 138(2):236-41. PubMed ID: 9602867
[TBL] [Abstract][Full Text] [Related]
9. Dramatic response to nivolumab in xeroderma pigmentosum skin tumor.
Chambon F; Osdoit S; Bagny K; Moro A; Nguyen J; Réguerre Y
Pediatr Blood Cancer; 2018 Feb; 65(2):. PubMed ID: 28988442
[TBL] [Abstract][Full Text] [Related]
10. Xeroderma pigmentosum: neck lymph node metastasis of a squamous cell carcinoma of the skin treated with cetuximab.
Rubió Casadevall J; Graña-Suárez B; Hernandez-Yagüe X; Vayreda Ribera J; Huc Grasa O; Brunet Vidal J
Eur J Dermatol; 2009; 19(2):163-5. PubMed ID: 19106040
[TBL] [Abstract][Full Text] [Related]
11. [Radiotherapy for cutaneous cancers with xeroderma pigmentosum].
Ben Salah H; Bahri M; Turki H; Abdelmoula M; Frikha M; Daoud J
Cancer Radiother; 2011 Aug; 15(5):400-3. PubMed ID: 21664850
[TBL] [Abstract][Full Text] [Related]
12. Xeroderma pigmentosum variant or pigmented xerodermoid.
Somos S; Schneider I; Raskó I
Anticancer Res; 1997; 17(1B):753-6. PubMed ID: 9066615
[TBL] [Abstract][Full Text] [Related]
13. Prevention of skin cancer in xeroderma pigmentosum with oral isotretinoin.
Moshell AN
Cutis; 1989 May; 43(5):485-90. PubMed ID: 2721244
[TBL] [Abstract][Full Text] [Related]
14. Retinoid chemoprevention in the high-risk patient.
DiGiovanna JJ
J Am Acad Dermatol; 1998 Aug; 39(2 Pt 3):S82-5. PubMed ID: 9703130
[No Abstract] [Full Text] [Related]
15. Chemoprevention of skin cancer in xeroderma pigmentosum.
Kraemer KH; DiGiovanna JJ; Peck GL
J Dermatol; 1992 Nov; 19(11):715-8. PubMed ID: 1293159
[TBL] [Abstract][Full Text] [Related]
16. [Therapeutic results of 5-fluorouracil in multiple and unresectable facial carcinoma secondary to xeroderma pigmentosum].
Boussen H; Zwik J; Mili-Boussen I; Rammeh N; Bouaouina N; Gritli S; el May A; Kammoun MR; Ouertani A; Ladgham A
Therapie; 2001; 56(6):751-4. PubMed ID: 11878102
[TBL] [Abstract][Full Text] [Related]
17. Alternative management of cutaneous squamous cell carcinoma in an elderly man: report of a case and review of the literature.
Tantranond P; Balducci L; Karam F; Wang TY; Parker M; Hescock H; Cherryholmes D
J Am Geriatr Soc; 1992 May; 40(5):510-2. PubMed ID: 1634707
[No Abstract] [Full Text] [Related]
18. Treatment of xeroderma pigmentosum variant with low-dose etretinate.
Finkelstein E; Lazarov A; Halevy S
Br J Dermatol; 1996 Apr; 134(4):815-6. PubMed ID: 8733405
[No Abstract] [Full Text] [Related]
19. Topical 5-fluorouracil to treat multiple or unresectable facial squamous cell carcinomas in xeroderma pigmentosum.
Hamouda B; Jamila Z; Najet R; Slim T; Rafiaa N; Noureddine B; Ahmed EM; Mohamed F; Ridha KM; Abderrahman L
J Am Acad Dermatol; 2001 Jun; 44(6):1054. PubMed ID: 11369927
[No Abstract] [Full Text] [Related]
20. [Xeroderma pigmentosum: report of 6 cases in Dakar].
Dieng MT; Niang SO; Dangou JM; Ndiaye B
Bull Cancer; 2001 Feb; 88(2):199-202. PubMed ID: 11257594
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
